Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nitric Oxide for Regional Blood Flow in Sickle Cell Disease
NCT00009581Phase 2Completed
- Sponsor
- National Institutes of Health
- Start
- Jan 2001
- Modality
- DNA Intercalators/Alkylators, Inhalation Devices
- Countries
- 1
01
Overview
A Phase 2 trial of nitric oxide in sickle cell anemia (SCA), sponsored by National Institutes of Health. Started Jan 2001; status: completed.
02
Drugs
nitric oxide
03
Conditions
sickle cell anemia (SCA)
Beyond the preview
Go deeper on NCT00009581.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00009581.